Industry slams German reform's impact on medical technology aids quality
This article was originally published in Clinica
The German health reform law has effectively given the statutory health insurance funds (GKV) carte blanche to pressure prices and consequently endanger quality in the medical technical aids sector. This was the view expressed last week by the German industrial association for optical, medical and mechatronical technologies, Spectaris.
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.